1 Market Overview 1.1 Graves Disease Treatment Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Graves Disease Treatment Revenue by Type: 2017 Versus 2021 Versus 2028 1.2.2 Anti-Thyroid Medication 1.2.3 Radioactive Iodine Therapy 1.3 Market Analysis by Application 1.3.1 Overview: Global Graves Disease Treatment Revenue by Application: 2017 Versus 2021 Versus 2028 1.3.2 Hospitals Pharmacies 1.3.3 Retail Pharmacies 1.4 Global Graves Disease Treatment Market Size & Forecast 1.4.1 Global Graves Disease Treatment Sales in Value (2017 & 2021 & 2028) 1.4.2 Global Graves Disease Treatment Sales in Volume (2017-2028) 1.4.3 Global Graves Disease Treatment Price (2017-2028) 1.5 Global Graves Disease Treatment Production Capacity Analysis 1.5.1 Global Graves Disease Treatment Total Production Capacity (2017-2028) 1.5.2 Global Graves Disease Treatment Production Capacity by Geographic Region 1.6 Market Drivers, Restraints and Trends 1.6.1 Graves Disease Treatment Market Drivers 1.6.2 Graves Disease Treatment Market Restraints 1.6.3 Graves Disease Treatment Trends Analysis 2 Manufacturers Profiles 2.1 Abbott 2.1.1 Abbott Details 2.1.2 Abbott Major Business 2.1.3 Abbott Graves Disease Treatment Product and Services 2.1.4 Abbott Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.2 GlaxoSmithKline plc 2.2.1 GlaxoSmithKline plc Details 2.2.2 GlaxoSmithKline plc Major Business 2.2.3 GlaxoSmithKline plc Graves Disease Treatment Product and Services 2.2.4 GlaxoSmithKline plc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.3 Merck & Co 2.3.1 Merck & Co Details 2.3.2 Merck & Co Major Business 2.3.3 Merck & Co Graves Disease Treatment Product and Services 2.3.4 Merck & Co Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.4 Pfizer, Inc 2.4.1 Pfizer, Inc Details 2.4.2 Pfizer, Inc Major Business 2.4.3 Pfizer, Inc Graves Disease Treatment Product and Services 2.4.4 Pfizer, Inc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.5 RLC LABS 2.5.1 RLC LABS Details 2.5.2 RLC LABS Major Business 2.5.3 RLC LABS Graves Disease Treatment Product and Services 2.5.4 RLC LABS Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.6 AbbVie, Inc 2.6.1 AbbVie, Inc Details 2.6.2 AbbVie, Inc Major Business 2.6.3 AbbVie, Inc Graves Disease Treatment Product and Services 2.6.4 AbbVie, Inc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.7 Mylan N.V 2.7.1 Mylan N.V Details 2.7.2 Mylan N.V Major Business 2.7.3 Mylan N.V Graves Disease Treatment Product and Services 2.7.4 Mylan N.V Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.8 Allergan, plc 2.8.1 Allergan, plc Details 2.8.2 Allergan, plc Major Business 2.8.3 Allergan, plc Graves Disease Treatment Product and Services 2.8.4 Allergan, plc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.9 Novartis AG 2.9.1 Novartis AG Details 2.9.2 Novartis AG Major Business 2.9.3 Novartis AG Graves Disease Treatment Product and Services 2.9.4 Novartis AG Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.10 Apitope 2.10.1 Apitope Details 2.10.2 Apitope Major Business 2.10.3 Apitope Graves Disease Treatment Product and Services 2.10.4 Apitope Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.11 Amgen INC. 2.11.1 Amgen INC. Details 2.11.2 Amgen INC. Major Business 2.11.3 Amgen INC. Graves Disease Treatment Product and Services 2.11.4 Amgen INC. Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.12 Sun Pharmaceuticals Industries LTD 2.12.1 Sun Pharmaceuticals Industries LTD Details 2.12.2 Sun Pharmaceuticals Industries LTD Major Business 2.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product and Services 2.12.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.13 Immunovant Inc 2.13.1 Immunovant Inc Details 2.13.2 Immunovant Inc Major Business 2.13.3 Immunovant Inc Graves Disease Treatment Product and Services 2.13.4 Immunovant Inc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 3 Graves Disease Treatment Breakdown Data by Manufacturer 3.1 Global Graves Disease Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022) 3.2 Global Graves Disease Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022) 3.3 Key Manufacturer Market Position in Graves Disease Treatment 3.4 Market Concentration Rate 3.4.1 Top 3 Graves Disease Treatment Manufacturer Market Share in 2021 3.4.2 Top 6 Graves Disease Treatment Manufacturer Market Share in 2021 3.5 Global Graves Disease Treatment Production Capacity by Company: 2021 VS 2022 3.6 Manufacturer by Geography: Head Office and Graves Disease Treatment Production Site 3.7 New Entrant and Capacity Expansion Plans 3.8 Mergers & Acquisitions 4 Market Analysis by Region 4.1 Global Graves Disease Treatment Market Size by Region 4.1.1 Global Graves Disease Treatment Sales in Volume by Region (2017-2028) 4.1.2 Global Graves Disease Treatment Revenue by Region (2017-2028) 4.2 North America Graves Disease Treatment Revenue (2017-2028) 4.3 Europe Graves Disease Treatment Revenue (2017-2028) 4.4 Asia-Pacific Graves Disease Treatment Revenue (2017-2028) 4.5 South America Graves Disease Treatment Revenue (2017-2028) 4.6 Middle East and Africa Graves Disease Treatment Revenue (2017-2028) 5 Market Segment by Type 5.1 Global Graves Disease Treatment Sales in Volume by Type (2017-2028) 5.2 Global Graves Disease Treatment Revenue by Type (2017-2028) 5.3 Global Graves Disease Treatment Price by Type (2017-2028) 6 Market Segment by Application 6.1 Global Graves Disease Treatment Sales in Volume by Application (2017-2028) 6.2 Global Graves Disease Treatment Revenue by Application (2017-2028) 6.3 Global Graves Disease Treatment Price by Application (2017-2028) 7 North America by Country, by Type, and by Application 7.1 North America Graves Disease Treatment Sales by Type (2017-2028) 7.2 North America Graves Disease Treatment Sales by Application (2017-2028) 7.3 North America Graves Disease Treatment Market Size by Country 7.3.1 North America Graves Disease Treatment Sales in Volume by Country (2017-2028) 7.3.2 North America Graves Disease Treatment Revenue by Country (2017-2028) 7.3.3 United States Market Size and Forecast (2017-2028) 7.3.4 Canada Market Size and Forecast (2017-2028) 7.3.5 Mexico Market Size and Forecast (2017-2028) 8 Europe by Country, by Type, and by Application 8.1 Europe Graves Disease Treatment Sales by Type (2017-2028) 8.2 Europe Graves Disease Treatment Sales by Application (2017-2028) 8.3 Europe Graves Disease Treatment Market Size by Country 8.3.1 Europe Graves Disease Treatment Sales in Volume by Country (2017-2028) 8.3.2 Europe Graves Disease Treatment Revenue by Country (2017-2028) 8.3.3 Germany Market Size and Forecast (2017-2028) 8.3.4 France Market Size and Forecast (2017-2028) 8.3.5 United Kingdom Market Size and Forecast (2017-2028) 8.3.6 Russia Market Size and Forecast (2017-2028) 8.3.7 Italy Market Size and Forecast (2017-2028) 9 Asia-Pacific by Region, by Type, and by Application 9.1 Asia-Pacific Graves Disease Treatment Sales by Type (2017-2028) 9.2 Asia-Pacific Graves Disease Treatment Sales by Application (2017-2028) 9.3 Asia-Pacific Graves Disease Treatment Market Size by Region 9.3.1 Asia-Pacific Graves Disease Treatment Sales in Volume by Region (2017-2028) 9.3.2 Asia-Pacific Graves Disease Treatment Revenue by Region (2017-2028) 9.3.3 China Market Size and Forecast (2017-2028) 9.3.4 Japan Market Size and Forecast (2017-2028) 9.3.5 Korea Market Size and Forecast (2017-2028) 9.3.6 India Market Size and Forecast (2017-2028) 9.3.7 Southeast Asia Market Size and Forecast (2017-2028) 9.3.8 Australia Market Size and Forecast (2017-2028) 10 South America by Region, by Type, and by Application 10.1 South America Graves Disease Treatment Sales by Type (2017-2028) 10.2 South America Graves Disease Treatment Sales by Application (2017-2028) 10.3 South America Graves Disease Treatment Market Size by Country 10.3.1 South America Graves Disease Treatment Sales in Volume by Country (2017-2028) 10.3.2 South America Graves Disease Treatment Revenue by Country (2017-2028) 10.3.3 Brazil Market Size and Forecast (2017-2028) 10.3.4 Argentina Market Size and Forecast (2017-2028) 11 Middle East & Africa by Country, by Type, and by Application 11.1 Middle East & Africa Graves Disease Treatment Sales by Type (2017-2028) 11.2 Middle East & Africa Graves Disease Treatment Sales by Application (2017-2028) 11.3 Middle East & Africa Graves Disease Treatment Market Size by Country 11.3.1 Middle East & Africa Graves Disease Treatment Sales in Volume by Country (2017-2028) 11.3.2 Middle East & Africa Graves Disease Treatment Revenue by Country (2017-2028) 11.3.3 Turkey Market Size and Forecast (2017-2028) 11.3.4 Egypt Market Size and Forecast (2017-2028) 11.3.5 Saudi Arabia Market Size and Forecast (2017-2028) 11.3.6 South Africa Market Size and Forecast (2017-2028) 12 Raw Material and Industry Chain 12.1 Raw Material of Graves Disease Treatment and Key Manufacturers 12.2 Manufacturing Costs Percentage of Graves Disease Treatment 12.3 Graves Disease Treatment Production Process 12.4 Graves Disease Treatment Industrial Chain 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Graves Disease Treatment Typical Distributors 13.3 Graves Disease Treatment Typical Customers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Research Process and Data Source 15.3 Disclaimer

List of Tables Table 1. Global Graves Disease Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028 Table 2. Global Graves Disease Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028 Table 3. Abbott Basic Information, Manufacturing Base and Competitors Table 4. Abbott Major Business Table 5. Abbott Graves Disease Treatment Product and Services Table 6. Abbott Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 7. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors Table 8. GlaxoSmithKline plc Major Business Table 9. GlaxoSmithKline plc Graves Disease Treatment Product and Services Table 10. GlaxoSmithKline plc Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 11. Merck & Co Basic Information, Manufacturing Base and Competitors Table 12. Merck & Co Major Business Table 13. Merck & Co Graves Disease Treatment Product and Services Table 14. Merck & Co Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 15. Pfizer, Inc Basic Information, Manufacturing Base and Competitors Table 16. Pfizer, Inc Major Business Table 17. Pfizer, Inc Graves Disease Treatment Product and Services Table 18. Pfizer, Inc Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 19. RLC LABS Basic Information, Manufacturing Base and Competitors Table 20. RLC LABS Major Business Table 21. RLC LABS Graves Disease Treatment Product and Services Table 22. RLC LABS Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 23. AbbVie, Inc Basic Information, Manufacturing Base and Competitors Table 24. AbbVie, Inc Major Business Table 25. AbbVie, Inc Graves Disease Treatment Product and Services Table 26. AbbVie, Inc Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 27. Mylan N.V Basic Information, Manufacturing Base and Competitors Table 28. Mylan N.V Major Business Table 29. Mylan N.V Graves Disease Treatment Product and Services Table 30. Mylan N.V Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 31. Allergan, plc Basic Information, Manufacturing Base and Competitors Table 32. Allergan, plc Major Business Table 33. Allergan, plc Graves Disease Treatment Product and Services Table 34. Allergan, plc Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 35. Novartis AG Basic Information, Manufacturing Base and Competitors Table 36. Novartis AG Major Business Table 37. Novartis AG Graves Disease Treatment Product and Services Table 38. Novartis AG Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 39. Apitope Basic Information, Manufacturing Base and Competitors Table 40. Apitope Major Business Table 41. Apitope Graves Disease Treatment Product and Services Table 42. Apitope Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 43. Amgen INC. Basic Information, Manufacturing Base and Competitors Table 44. Amgen INC. Major Business Table 45. Amgen INC. Graves Disease Treatment Product and Services Table 46. Amgen INC. Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 47. Sun Pharmaceuticals Industries LTD Basic Information, Manufacturing Base and Competitors Table 48. Sun Pharmaceuticals Industries LTD Major Business Table 49. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product and Services Table 50. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 51. Immunovant Inc Basic Information, Manufacturing Base and Competitors Table 52. Immunovant Inc Major Business Table 53. Immunovant Inc Graves Disease Treatment Product and Services Table 54. Immunovant Inc Graves Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 55. Global Graves Disease Treatment Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units) Table 56. Global Graves Disease Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million) Table 57. Market Position of Manufacturers in Graves Disease Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021 Table 58. Global Graves Disease Treatment Production Capacity by Company, (K Units): 2020 VS 2021 Table 59. Head Office and Graves Disease Treatment Production Site of Key Manufacturer Table 60. Graves Disease Treatment New Entrant and Capacity Expansion Plans Table 61. Graves Disease Treatment Mergers & Acquisitions in the Past Five Years Table 62. Global Graves Disease Treatment Sales by Region (2017-2022) & (K Units) Table 63. Global Graves Disease Treatment Sales by Region (2023-2028) & (K Units) Table 64. Global Graves Disease Treatment Revenue by Region (2017-2022) & (USD Million) Table 65. Global Graves Disease Treatment Revenue by Region (2023-2028) & (USD Million) Table 66. Global Graves Disease Treatment Sales by Type (2017-2022) & (K Units) Table 67. Global Graves Disease Treatment Sales by Type (2023-2028) & (K Units) Table 68. Global Graves Disease Treatment Revenue by Type (2017-2022) & (USD Million) Table 69. Global Graves Disease Treatment Revenue by Type (2023-2028) & (USD Million) Table 70. Global Graves Disease Treatment Price by Type (2017-2022) & (US$/Unit) Table 71. Global Graves Disease Treatment Price by Type (2023-2028) & (US$/Unit) Table 72. Global Graves Disease Treatment Sales by Application (2017-2022) & (K Units) Table 73. Global Graves Disease Treatment Sales by Application (2023-2028) & (K Units) Table 74. Global Graves Disease Treatment Revenue by Application (2017-2022) & (USD Million) Table 75. Global Graves Disease Treatment Revenue by Application (2023-2028) & (USD Million) Table 76. Global Graves Disease Treatment Price by Application (2017-2022) & (US$/Unit) Table 77. Global Graves Disease Treatment Price by Application (2023-2028) & (US$/Unit) Table 78. North America Graves Disease Treatment Sales by Country (2017-2022) & (K Units) Table 79. North America Graves Disease Treatment Sales by Country (2023-2028) & (K Units) Table 80. North America Graves Disease Treatment Revenue by Country (2017-2022) & (USD Million) Table 81. North America Graves Disease Treatment Revenue by Country (2023-2028) & (USD Million) Table 82. North America Graves Disease Treatment Sales by Type (2017-2022) & (K Units) Table 83. North America Graves Disease Treatment Sales by Type (2023-2028) & (K Units) Table 84. North America Graves Disease Treatment Sales by Application (2017-2022) & (K Units) Table 85. North America Graves Disease Treatment Sales by Application (2023-2028) & (K Units) Table 86. Europe Graves Disease Treatment Sales by Country (2017-2022) & (K Units) Table 87. Europe Graves Disease Treatment Sales by Country (2023-2028) & (K Units) Table 88. Europe Graves Disease Treatment Revenue by Country (2017-2022) & (USD Million) Table 89. Europe Graves Disease Treatment Revenue by Country (2023-2028) & (USD Million) Table 90. Europe Graves Disease Treatment Sales by Type (2017-2022) & (K Units) Table 91. Europe Graves Disease Treatment Sales by Type (2023-2028) & (K Units) Table 92. Europe Graves Disease Treatment Sales by Application (2017-2022) & (K Units) Table 93. Europe Graves Disease Treatment Sales by Application (2023-2028) & (K Units) Table 94. Asia-Pacific Graves Disease Treatment Sales by Region (2017-2022) & (K Units) Table 95. Asia-Pacific Graves Disease Treatment Sales by Region (2023-2028) & (K Units) Table 96. Asia-Pacific Graves Disease Treatment Revenue by Region (2017-2022) & (USD Million) Table 97. Asia-Pacific Graves Disease Treatment Revenue by Region (2023-2028) & (USD Million) Table 98. Asia-Pacific Graves Disease Treatment Sales by Type (2017-2022) & (K Units) Table 99. Asia-Pacific Graves Disease Treatment Sales by Type (2023-2028) & (K Units) Table 100. Asia-Pacific Graves Disease Treatment Sales by Application (2017-2022) & (K Units) Table 101. Asia-Pacific Graves Disease Treatment Sales by Application (2023-2028) & (K Units) Table 102. South America Graves Disease Treatment Sales by Country (2017-2022) & (K Units) Table 103. South America Graves Disease Treatment Sales by Country (2023-2028) & (K Units) Table 104. South America Graves Disease Treatment Revenue by Country (2017-2022) & (USD Million) Table 105. South America Graves Disease Treatment Revenue by Country (2023-2028) & (USD Million) Table 106. South America Graves Disease Treatment Sales by Type (2017-2022) & (K Units) Table 107. South America Graves Disease Treatment Sales by Type (2023-2028) & (K Units) Table 108. South America Graves Disease Treatment Sales by Application (2017-2022) & (K Units) Table 109. South America Graves Disease Treatment Sales by Application (2023-2028) & (K Units) Table 110. Middle East & Africa Graves Disease Treatment Sales by Region (2017-2022) & (K Units) Table 111. Middle East & Africa Graves Disease Treatment Sales by Region (2023-2028) & (K Units) Table 112. Middle East & Africa Graves Disease Treatment Revenue by Region (2017-2022) & (USD Million) Table 113. Middle East & Africa Graves Disease Treatment Revenue by Region (2023-2028) & (USD Million) Table 114. Middle East & Africa Graves Disease Treatment Sales by Type (2017-2022) & (K Units) Table 115. Middle East & Africa Graves Disease Treatment Sales by Type (2023-2028) & (K Units) Table 116. Middle East & Africa Graves Disease Treatment Sales by Application (2017-2022) & (K Units) Table 117. Middle East & Africa Graves Disease Treatment Sales by Application (2023-2028) & (K Units) Table 118. Graves Disease Treatment Raw Material Table 119. Key Manufacturers of Graves Disease Treatment Raw Materials Table 120. Direct Channel Pros & Cons Table 121. Indirect Channel Pros & Cons Table 122. Graves Disease Treatment Typical Distributors Table 123. Graves Disease Treatment Typical Customers List of Figures Figure 1. Graves Disease Treatment Picture Figure 2. Global Graves Disease Treatment Revenue Market Share by Type in 2021 Figure 3. Anti-Thyroid Medication Figure 4. Radioactive Iodine Therapy Figure 5. Global Graves Disease Treatment Revenue Market Share by Application in 2021 Figure 6. Hospitals Pharmacies Figure 7. Retail Pharmacies Figure 8. Global Graves Disease Treatment Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028 Figure 9. Global Graves Disease Treatment Revenue and Forecast (2017-2028) & (USD Million) Figure 10. Global Graves Disease Treatment Sales (2017-2028) & (K Units) Figure 11. Global Graves Disease Treatment Price (2017-2028) & (US$/Unit) Figure 12. Global Graves Disease Treatment Production Capacity (2017-2028) & (K Units) Figure 13. Global Graves Disease Treatment Production Capacity by Geographic Region: 2022 VS 2028 Figure 14. Graves Disease Treatment Market Drivers Figure 15. Graves Disease Treatment Market Restraints Figure 16. Graves Disease Treatment Market Trends Figure 17. Global Graves Disease Treatment Sales Market Share by Manufacturer in 2021 Figure 18. Global Graves Disease Treatment Revenue Market Share by Manufacturer in 2021 Figure 19. Graves Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021 Figure 20. Top 3 Graves Disease Treatment Manufacturer (Revenue) Market Share in 2021 Figure 21. Top 6 Graves Disease Treatment Manufacturer (Revenue) Market Share in 2021 Figure 22. Global Graves Disease Treatment Sales Market Share by Region (2017-2028) Figure 23. Global Graves Disease Treatment Revenue Market Share by Region (2017-2028) Figure 24. North America Graves Disease Treatment Revenue (2017-2028) & (USD Million) Figure 25. Europe Graves Disease Treatment Revenue (2017-2028) & (USD Million) Figure 26. Asia-Pacific Graves Disease Treatment Revenue (2017-2028) & (USD Million) Figure 27. South America Graves Disease Treatment Revenue (2017-2028) & (USD Million) Figure 28. Middle East & Africa Graves Disease Treatment Revenue (2017-2028) & (USD Million) Figure 29. Global Graves Disease Treatment Sales Market Share by Type (2017-2028) Figure 30. Global Graves Disease Treatment Revenue Market Share by Type (2017-2028) Figure 31. Global Graves Disease Treatment Price by Type (2017-2028) & (US$/Unit) Figure 32. Global Graves Disease Treatment Sales Market Share by Application (2017-2028) Figure 33. Global Graves Disease Treatment Revenue Market Share by Application (2017-2028) Figure 34. Global Graves Disease Treatment Price by Application (2017-2028) & (US$/Unit) Figure 35. North America Graves Disease Treatment Sales Market Share by Type (2017-2028) Figure 36. North America Graves Disease Treatment Sales Market Share by Application (2017-2028) Figure 37. North America Graves Disease Treatment Sales Market Share by Country (2017-2028) Figure 38. North America Graves Disease Treatment Revenue Market Share by Country (2017-2028) Figure 39. United States Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 40. Canada Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 41. Mexico Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 42. Europe Graves Disease Treatment Sales Market Share by Type (2017-2028) Figure 43. Europe Graves Disease Treatment Sales Market Share by Application (2017-2028) Figure 44. Europe Graves Disease Treatment Sales Market Share by Country (2017-2028) Figure 45. Europe Graves Disease Treatment Revenue Market Share by Country (2017-2028) Figure 46. Germany Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 47. France Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 48. United Kingdom Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 49. Russia Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 50. Italy Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 51. Asia-Pacific Graves Disease Treatment Sales Market Share by Region (2017-2028) Figure 52. Asia-Pacific Graves Disease Treatment Sales Market Share by Application (2017-2028) Figure 53. Asia-Pacific Graves Disease Treatment Sales Market Share by Region (2017-2028) Figure 54. Asia-Pacific Graves Disease Treatment Revenue Market Share by Region (2017-2028) Figure 55. China Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 56. Japan Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 57. Korea Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. India Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. Southeast Asia Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Australia Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. South America Graves Disease Treatment Sales Market Share by Type (2017-2028) Figure 62. South America Graves Disease Treatment Sales Market Share by Application (2017-2028) Figure 63. South America Graves Disease Treatment Sales Market Share by Country (2017-2028) Figure 64. South America Graves Disease Treatment Revenue Market Share by Country (2017-2028) Figure 65. Brazil Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 66. Argentina Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. Middle East & Africa Graves Disease Treatment Sales Market Share by Type (2017-2028) Figure 68. Middle East & Africa Graves Disease Treatment Sales Market Share by Application (2017-2028) Figure 69. Middle East & Africa Graves Disease Treatment Sales Market Share by Region (2017-2028) Figure 70. Middle East & Africa Graves Disease Treatment Revenue Market Share by Region (2017-2028) Figure 71. Turkey Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 72. Egypt Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 73. Saudi Arabia Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 74. South Africa Graves Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. Manufacturing Cost Structure Analysis of Graves Disease Treatment in 2021 Figure 76. Manufacturing Process Analysis of Graves Disease Treatment Figure 77. Graves Disease Treatment Industrial Chain Figure 78. Sales Channel: Direct Channel vs Indirect Channel Figure 79. Methodology Figure 80. Research Process and Data Source

Abbott GlaxoSmithKline plc Merck & Co Pfizer, Inc RLC LABS AbbVie, Inc Mylan N.V Allergan, plc Novartis AG Apitope Amgen INC. Sun Pharmaceuticals Industries LTD Immunovant Inc